GridAI Technologies Corp. (GRDX) company profile
Close on Nov 17, 2026Market cap $17.46TP/E –Yield –
About GridAI Technologies
Electric & Other Services Combined, SIC 4931
GridAI Technologies Corp. is a diversified technology and biopharmaceutical company operating across two main areas: energy orchestration software and legacy biopharmaceutical development. Through its subsidiary Grid AI Corp., the company develops energy infrastructure optimization software and an artificial intelligence data center platform designed to manage distributed energy resources, such as battery energy storage systems, on-site generation, and grid interconnections. The subsidiary also maintains legacy front-of-meter load-shaping and residential home energy management platforms. In life sciences, the company conducts research on Adrulipase, an oral recombinant enzyme therapy intended to treat exocrine pancreatic insufficiency. Prospective customers for the energy platform include AI data center developers, hyperscalers, and energy infrastructure developers, alongside ongoing discussions with battery storage providers.
The company operates across North America and Australia, where it is pursuing market opportunities and pilot deployments, while also re-evaluating distributed energy management in the United Kingdom. Corporate headquarters details are not specified in the text.
Summary of the business section of GridAI Technologies's latest annual report, written by StockData.
Company profile
Company
- Legal name
- GridAI Technologies Corp.
- Founded
- 2014
- Headquarters
- Boca Raton, FL
- Address
- 433 Plaza Real, Suite 275
- Phone
- (561) 589-7020
- Website
- grid-ai.com
- Employees
- 2, Dec 31, 2025
- Industry
- Electric & Other Services Combined
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Macias Gini & OConnell LLP, Irvine, CA
Stock & identifiers
- Ticker
- GRDX
- Former tickers
- ENTO until Aug 21, 2026; FWBI until May 30, 2024; AZRX until Sep 21, 2021
- Exchange
- Nasdaq
- IPO date
- Oct 13, 2016
- Shares outstanding
- 7M, Aug 21, 2026
- Public float
- $14.90M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-3 reverse, Aug 18, 2025; 1-for-20 reverse, Dec 18, 2023; 1-for-7 reverse, Jan 18, 2023; 1-for-30 reverse, Aug 26, 2022; 2472721-for-1, Mar 31, 2022; 1-for-10 reverse, Sep 13, 2021
- SEC CIK
- 1604191
- CUSIP
- 33749P507
- ISIN
- US33749P5070
- FIGI
- BBG00DBBJ4T4
- Share class FIGI
- BBG00DBBJ4V1
- LEI
- 549300I3YKRXWGWPG039
- EIN
- 46-4993860
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jason David Sawyer | Chief Executive Officer, Director | 1,080,000 |
| Richard Paolone | Interim CEO, Director | – |
| Anna Skowron | Interim CFO | 140,000 |
| Sarah Romano | Chief Financial Officer | 17,287 |
| Edward Borkowski | Director | 191,007 |
| Geordan Garrett Pursglove | Director | 140,000 |
| Jack Syage | Director | 95,400 |
| Eric Corbett | Director | – |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2024 | $510.31K | $510.31K | $451.36K | $-0 | – |
| FY2023 | $1.25M | $671.31K | $810.56K | $-28 | – |
| FY2022 | $741.72K | $184.27K | $389.87K | $-48 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2024
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|
| James Sapirstein Former Chief Executive Officer | $416.30K | $76.40K | $17.61K | $510.31K | -59% |
| Sarah Romano Former Chief Financial Officer | $424.62K | $26.74K | – | $451.36K | -44% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Oct 13, 2016
- Offer price
- $5.50
- Securities offered
- 960,000
- Gross proceeds
- $5.28M
- Exchange
- Nasdaq
- First trading day
- Oct 11, 2016
- First-day close
- $4.98-9.5%
- Lock-up ends (est.)
- Apr 9, 2017
“The initial public offering price will be $5.50 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 2 full-time employees at the parent company level.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?